Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SRIVARU (SVMH) CEO Mohan Ramasamy Discusses Latest Developments Related to PRANA 2.0 on Proactiveinvestors.com
-
Wearable Devices Delivered Custom Touchless Technology for a Leading Global Defense Company
-
Fundamental Global Inc. Reports First Quarter 2024 Financial Results
-
Blackwells Releases Presentation Exposing Monty Bennett’s Buffoonery
-
Presto Announces Pilot of Spanish Voice AI for Drive-Thrus
-
LIXTE Biotechnology Holdings Provides Update on Recent Activities
-
NANO Nuclear’s Executive Advisory Board Member General (ret) Wesley K. Clark, former NATO Supreme Allied Commander, Congratulates Company on Becoming the First Portable Microreactor Company to Publi
-
Heritage Distilling Company Launches Digital Memorial Day Wall to Honor Our Nation’s Fallen Heroes
-
Lead Real Estate Co., Ltd. to Participate in Nasdaq Japan IR Event on June 20, 2024
-
NETSOL Technologies Reports 14% Revenue Growth and EPS of $0.03 in Fiscal Third Quarter 2024
-
Duck Creek Technologies Announces New Chief Marketing Officer
-
Nanox to Report First Quarter and Financial Results on May 28, 2024
-
Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer
-
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer a
-
Richmond National Group, Inc. Announces Completion of Follow-On Equity Capital Raise
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Nominations Now Open for the Nation’s Most Beautiful Hospitals
-
Gray Television Commences Cash Tender Offer for Its 5.875% Senior Notes Due 2026
-
Gray Announces Private Offering of Senior Secured Notes
-
Launch Your Merch FREE 4-Day Challenge Empowers Entrepreneurs to Build Profitable Merch Stores Online
-
ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING
-
Bridger Aerospace Responds to Concerns Over Politically Motivated Attacks on its Business
-
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease
-
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
-
BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation For Potential Securities Violations and Breaches of Fiduciary Duty
-
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
-
Seacoast Bank Welcomes Tony Coley as Regional President, South Florida
-
Prosper Gold Provides Update on Option Agreement to Acquire the Kaza and Northstar Properties
-
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference
-
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau) for the Diagnosis of Progressive Supranuclear Palsy
-
Zehnder’s of Frankenmuth Announces Future Plans
-
Sow Good to Ring the Nasdaq Opening Bell Today, May 20, 2024
-
Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile X Syndrome
-
NV5 Strengthens Subscription-Based Services with Acquisition of myBIMteam
-
CervoMed to Appoint William Elder as Chief Financial Officer
-
GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Advanced Solid Tumors
-
Infinera Names Regan MacPherson Chief Legal Officer and Corporate Secretary
-
ABM Recognized as One of the Best Places to Work in Healthcare
-
PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
-
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Volta Medical presents results from the first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with the conventional treatment for persistent atrial fibrillation pati
-
Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
-
Cerevance to Participate in Precision Neurotherapeutics Panel During the 2024 BIO International Convention
-
Telesign Recognized as the Best Fraud Protection Company by the Cybersecurity Excellence Awards
-
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
-
Genius Group Announces Exercise of Warrants for $3.8 Million Gross Proceeds
-
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
-
InnovAge Welcomes John Koehn as Senior Vice President of External Affairs
-
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility
-
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting

